nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—CA6—saliva—bipolar disorder	0.02	0.0482	CbGeAlD
Nilotinib—Imatinib—NTRK1—bipolar disorder	0.0124	1	CrCbGaD
Nilotinib—UGT1A1—urine—bipolar disorder	0.0115	0.0278	CbGeAlD
Nilotinib—LYN—blood plasma—bipolar disorder	0.0112	0.0269	CbGeAlD
Nilotinib—MAPK14—blood plasma—bipolar disorder	0.00768	0.0185	CbGeAlD
Nilotinib—CDC42BPB—adrenal cortex—bipolar disorder	0.00679	0.0164	CbGeAlD
Nilotinib—UGT1A1—blood plasma—bipolar disorder	0.00602	0.0145	CbGeAlD
Nilotinib—CSF1R—blood plasma—bipolar disorder	0.00556	0.0134	CbGeAlD
Nilotinib—TIE1—adrenal cortex—bipolar disorder	0.00532	0.0128	CbGeAlD
Nilotinib—KIT—blood plasma—bipolar disorder	0.00505	0.0122	CbGeAlD
Nilotinib—CYP2C9—urine—bipolar disorder	0.00485	0.0117	CbGeAlD
Nilotinib—MAPK11—thyroid gland—bipolar disorder	0.00477	0.0115	CbGeAlD
Nilotinib—CDC42BPB—thyroid gland—bipolar disorder	0.00473	0.0114	CbGeAlD
Nilotinib—HCK—adrenal cortex—bipolar disorder	0.00465	0.0112	CbGeAlD
Nilotinib—CA1—blood plasma—bipolar disorder	0.00462	0.0111	CbGeAlD
Nilotinib—EPHB2—nervous system—bipolar disorder	0.0045	0.0109	CbGeAlD
Nilotinib—EPHA3—thyroid gland—bipolar disorder	0.00448	0.0108	CbGeAlD
Nilotinib—EPHA8—nervous system—bipolar disorder	0.00431	0.0104	CbGeAlD
Nilotinib—MAPK8—thyroid gland—bipolar disorder	0.00428	0.0103	CbGeAlD
Nilotinib—EPHA8—cerebellum—bipolar disorder	0.00406	0.0098	CbGeAlD
Nilotinib—MAPK11—nervous system—bipolar disorder	0.00401	0.00968	CbGeAlD
Nilotinib—CDC42BPB—nervous system—bipolar disorder	0.00398	0.0096	CbGeAlD
Nilotinib—MAP4K1—thyroid gland—bipolar disorder	0.00389	0.00938	CbGeAlD
Nilotinib—MAPK11—cerebellum—bipolar disorder	0.00377	0.00911	CbGeAlD
Nilotinib—EPHA3—nervous system—bipolar disorder	0.00377	0.0091	CbGeAlD
Nilotinib—CDC42BPB—cerebellum—bipolar disorder	0.00374	0.00903	CbGeAlD
Nilotinib—TIE1—thyroid gland—bipolar disorder	0.00371	0.00895	CbGeAlD
Nilotinib—CYP3A4—urine—bipolar disorder	0.0037	0.00892	CbGeAlD
Nilotinib—EPHB4—adrenal cortex—bipolar disorder	0.0037	0.00892	CbGeAlD
Nilotinib—CYP2D6—urine—bipolar disorder	0.00364	0.00878	CbGeAlD
Nilotinib—EPHA2—adrenal cortex—bipolar disorder	0.00363	0.00875	CbGeAlD
Nilotinib—MAPK8—nervous system—bipolar disorder	0.0036	0.00868	CbGeAlD
Nilotinib—EPHA6—nervous system—bipolar disorder	0.0036	0.00868	CbGeAlD
Nilotinib—BRAF—thyroid gland—bipolar disorder	0.00355	0.00858	CbGeAlD
Nilotinib—TEK—adrenal cortex—bipolar disorder	0.00354	0.00854	CbGeAlD
Nilotinib—EPHB2—brain—bipolar disorder	0.00344	0.0083	CbGeAlD
Nilotinib—MAPK8—cerebellum—bipolar disorder	0.00338	0.00817	CbGeAlD
Nilotinib—LYN—nervous system—bipolar disorder	0.00332	0.00801	CbGeAlD
Nilotinib—EPHA8—brain—bipolar disorder	0.0033	0.00796	CbGeAlD
Nilotinib—HCK—thyroid gland—bipolar disorder	0.00324	0.00782	CbGeAlD
Nilotinib—ABL2—thyroid gland—bipolar disorder	0.00322	0.00777	CbGeAlD
Nilotinib—TIE1—nervous system—bipolar disorder	0.00312	0.00753	CbGeAlD
Nilotinib—MAPK11—brain—bipolar disorder	0.00307	0.0074	CbGeAlD
Nilotinib—CDC42BPB—brain—bipolar disorder	0.00304	0.00734	CbGeAlD
Nilotinib—CA2—blood plasma—bipolar disorder	0.00299	0.00722	CbGeAlD
Nilotinib—EPHB3—nervous system—bipolar disorder	0.00297	0.00716	CbGeAlD
Nilotinib—EPHA4—thyroid gland—bipolar disorder	0.00295	0.00711	CbGeAlD
Nilotinib—TIE1—cerebellum—bipolar disorder	0.00293	0.00708	CbGeAlD
Nilotinib—CA3—thyroid gland—bipolar disorder	0.00291	0.00702	CbGeAlD
Nilotinib—MAP2K5—adrenal cortex—bipolar disorder	0.00289	0.00698	CbGeAlD
Nilotinib—EPHA3—brain—bipolar disorder	0.00288	0.00695	CbGeAlD
Nilotinib—CYP2C8—blood plasma—bipolar disorder	0.00285	0.00688	CbGeAlD
Nilotinib—CSF1R—adrenal cortex—bipolar disorder	0.00282	0.00681	CbGeAlD
Nilotinib—BRAF—cerebellum—bipolar disorder	0.00281	0.00679	CbGeAlD
Nilotinib—EPHB3—cerebellum—bipolar disorder	0.00279	0.00674	CbGeAlD
Nilotinib—MAPK8—brain—bipolar disorder	0.00275	0.00663	CbGeAlD
Nilotinib—EPHA6—brain—bipolar disorder	0.00275	0.00663	CbGeAlD
Nilotinib—HCK—nervous system—bipolar disorder	0.00273	0.00658	CbGeAlD
Nilotinib—MAPK14—thyroid gland—bipolar disorder	0.00272	0.00655	CbGeAlD
Nilotinib—FGR—thyroid gland—bipolar disorder	0.0027	0.00653	CbGeAlD
Nilotinib—LCK—thyroid gland—bipolar disorder	0.0027	0.00653	CbGeAlD
Nilotinib—EPHB4—thyroid gland—bipolar disorder	0.00257	0.00621	CbGeAlD
Nilotinib—CYP2B6—blood plasma—bipolar disorder	0.00256	0.00617	CbGeAlD
Nilotinib—ABL2—cerebellum—bipolar disorder	0.00255	0.00615	CbGeAlD
Nilotinib—LYN—brain—bipolar disorder	0.00254	0.00612	CbGeAlD
Nilotinib—CYP2C9—blood plasma—bipolar disorder	0.00253	0.00611	CbGeAlD
Nilotinib—EPHA2—thyroid gland—bipolar disorder	0.00253	0.0061	CbGeAlD
Nilotinib—CA7—cerebellum—bipolar disorder	0.00251	0.00606	CbGeAlD
Nilotinib—PDGFRB—adrenal cortex—bipolar disorder	0.0025	0.00604	CbGeAlD
Nilotinib—MAP4K1—brain—bipolar disorder	0.0025	0.00603	CbGeAlD
Nilotinib—EPHA4—nervous system—bipolar disorder	0.00248	0.00598	CbGeAlD
Nilotinib—TEK—thyroid gland—bipolar disorder	0.00246	0.00595	CbGeAlD
Nilotinib—CA3—nervous system—bipolar disorder	0.00245	0.00591	CbGeAlD
Nilotinib—TIE1—brain—bipolar disorder	0.00238	0.00575	CbGeAlD
Nilotinib—EPHB6—thyroid gland—bipolar disorder	0.00235	0.00568	CbGeAlD
Nilotinib—EPHA4—cerebellum—bipolar disorder	0.00233	0.00563	CbGeAlD
Nilotinib—BRAF—brain—bipolar disorder	0.00229	0.00551	CbGeAlD
Nilotinib—MAPK14—nervous system—bipolar disorder	0.00228	0.00551	CbGeAlD
Nilotinib—FGR—nervous system—bipolar disorder	0.00228	0.00549	CbGeAlD
Nilotinib—EPHB3—brain—bipolar disorder	0.00227	0.00547	CbGeAlD
Nilotinib—PDGFRA—thyroid gland—bipolar disorder	0.00223	0.00539	CbGeAlD
Nilotinib—ABL1—adrenal cortex—bipolar disorder	0.00223	0.00538	CbGeAlD
Nilotinib—CA9—cerebellum—bipolar disorder	0.0022	0.00532	CbGeAlD
Nilotinib—MAPK14—cerebellum—bipolar disorder	0.00215	0.00519	CbGeAlD
Nilotinib—EPHA2—nervous system—bipolar disorder	0.00212	0.00513	CbGeAlD
Nilotinib—CA14—cerebellum—bipolar disorder	0.00209	0.00505	CbGeAlD
Nilotinib—HCK—brain—bipolar disorder	0.00208	0.00503	CbGeAlD
Nilotinib—TEK—nervous system—bipolar disorder	0.00207	0.005	CbGeAlD
Nilotinib—ABL2—brain—bipolar disorder	0.00207	0.005	CbGeAlD
Nilotinib—CA7—brain—bipolar disorder	0.00204	0.00492	CbGeAlD
Nilotinib—EPHB4—cerebellum—bipolar disorder	0.00204	0.00492	CbGeAlD
Nilotinib—MAP2K5—thyroid gland—bipolar disorder	0.00201	0.00486	CbGeAlD
Nilotinib—EPHB6—nervous system—bipolar disorder	0.00198	0.00478	CbGeAlD
Nilotinib—CSF1R—thyroid gland—bipolar disorder	0.00197	0.00474	CbGeAlD
Nilotinib—TEK—cerebellum—bipolar disorder	0.00195	0.00471	CbGeAlD
Nilotinib—CYP3A4—blood plasma—bipolar disorder	0.00193	0.00466	CbGeAlD
Nilotinib—CYP2D6—blood plasma—bipolar disorder	0.0019	0.00458	CbGeAlD
Nilotinib—EPHA4—brain—bipolar disorder	0.00189	0.00457	CbGeAlD
Nilotinib—PDGFRA—nervous system—bipolar disorder	0.00188	0.00453	CbGeAlD
Nilotinib—CA3—brain—bipolar disorder	0.00187	0.00451	CbGeAlD
Nilotinib—EPHB6—cerebellum—bipolar disorder	0.00186	0.0045	CbGeAlD
Nilotinib—KIT—thyroid gland—bipolar disorder	0.00178	0.00431	CbGeAlD
Nilotinib—PDGFRA—cerebellum—bipolar disorder	0.00177	0.00426	CbGeAlD
Nilotinib—MAPK14—brain—bipolar disorder	0.00175	0.00421	CbGeAlD
Nilotinib—PDGFRB—thyroid gland—bipolar disorder	0.00174	0.00421	CbGeAlD
Nilotinib—FGR—brain—bipolar disorder	0.00174	0.0042	CbGeAlD
Nilotinib—CA12—nervous system—bipolar disorder	0.00173	0.00418	CbGeAlD
Nilotinib—CA14—brain—bipolar disorder	0.0017	0.0041	CbGeAlD
Nilotinib—MAP2K5—nervous system—bipolar disorder	0.00169	0.00409	CbGeAlD
Nilotinib—EPHB4—brain—bipolar disorder	0.00166	0.00399	CbGeAlD
Nilotinib—CSF1R—nervous system—bipolar disorder	0.00165	0.00399	CbGeAlD
Nilotinib—EPHA2—brain—bipolar disorder	0.00162	0.00392	CbGeAlD
Nilotinib—MAP2K5—cerebellum—bipolar disorder	0.00159	0.00385	CbGeAlD
Nilotinib—TEK—brain—bipolar disorder	0.00158	0.00382	CbGeAlD
Nilotinib—CSF1R—cerebellum—bipolar disorder	0.00156	0.00375	CbGeAlD
Nilotinib—ABL1—thyroid gland—bipolar disorder	0.00155	0.00375	CbGeAlD
Nilotinib—CA2—adrenal cortex—bipolar disorder	0.00152	0.00366	CbGeAlD
Nilotinib—EPHB6—brain—bipolar disorder	0.00151	0.00365	CbGeAlD
Nilotinib—KIT—nervous system—bipolar disorder	0.0015	0.00362	CbGeAlD
Nilotinib—PDGFRB—nervous system—bipolar disorder	0.00147	0.00354	CbGeAlD
Nilotinib—PDGFRA—brain—bipolar disorder	0.00144	0.00346	CbGeAlD
Nilotinib—KIT—cerebellum—bipolar disorder	0.00141	0.00341	CbGeAlD
Nilotinib—ABCG2—adrenal cortex—bipolar disorder	0.00141	0.00339	CbGeAlD
Nilotinib—PDGFRB—cerebellum—bipolar disorder	0.00138	0.00333	CbGeAlD
Nilotinib—CA1—nervous system—bipolar disorder	0.00137	0.00331	CbGeAlD
Nilotinib—ABCB1—blood plasma—bipolar disorder	0.00137	0.0033	CbGeAlD
Nilotinib—CA12—brain—bipolar disorder	0.00132	0.0032	CbGeAlD
Nilotinib—ABL1—nervous system—bipolar disorder	0.00131	0.00315	CbGeAlD
Nilotinib—CYP2B6—adrenal cortex—bipolar disorder	0.0013	0.00313	CbGeAlD
Nilotinib—MAP2K5—brain—bipolar disorder	0.00129	0.00312	CbGeAlD
Nilotinib—CA4—thyroid gland—bipolar disorder	0.00128	0.00308	CbGeAlD
Nilotinib—CSF1R—brain—bipolar disorder	0.00126	0.00305	CbGeAlD
Nilotinib—ABL1—cerebellum—bipolar disorder	0.00123	0.00297	CbGeAlD
Nilotinib—KIT—brain—bipolar disorder	0.00115	0.00277	CbGeAlD
Nilotinib—PDGFRB—brain—bipolar disorder	0.00112	0.0027	CbGeAlD
Nilotinib—CA4—nervous system—bipolar disorder	0.00107	0.00259	CbGeAlD
Nilotinib—CA2—thyroid gland—bipolar disorder	0.00106	0.00255	CbGeAlD
Nilotinib—CA1—brain—bipolar disorder	0.00105	0.00253	CbGeAlD
Nilotinib—CA4—cerebellum—bipolar disorder	0.00101	0.00244	CbGeAlD
Nilotinib—ABL1—brain—bipolar disorder	0.000999	0.00241	CbGeAlD
Nilotinib—ABCG2—thyroid gland—bipolar disorder	0.00098	0.00236	CbGeAlD
Nilotinib—CA2—nervous system—bipolar disorder	0.00089	0.00215	CbGeAlD
Nilotinib—CA2—cerebellum—bipolar disorder	0.000837	0.00202	CbGeAlD
Nilotinib—CA4—brain—bipolar disorder	0.00082	0.00198	CbGeAlD
Nilotinib—ABCG2—cerebellum—bipolar disorder	0.000775	0.00187	CbGeAlD
Nilotinib—CYP2B6—nervous system—bipolar disorder	0.00076	0.00183	CbGeAlD
Nilotinib—ABCB1—adrenal cortex—bipolar disorder	0.000694	0.00167	CbGeAlD
Nilotinib—CA2—brain—bipolar disorder	0.00068	0.00164	CbGeAlD
Nilotinib—CYP2C8—brain—bipolar disorder	0.000648	0.00156	CbGeAlD
Nilotinib—ABCG2—brain—bipolar disorder	0.00063	0.00152	CbGeAlD
Nilotinib—CYP2B6—brain—bipolar disorder	0.000581	0.0014	CbGeAlD
Nilotinib—CYP3A4—nervous system—bipolar disorder	0.000574	0.00139	CbGeAlD
Nilotinib—CYP2D6—nervous system—bipolar disorder	0.000565	0.00136	CbGeAlD
Nilotinib—CYP2D6—cerebellum—bipolar disorder	0.000532	0.00128	CbGeAlD
Nilotinib—ABCB1—thyroid gland—bipolar disorder	0.000483	0.00117	CbGeAlD
Nilotinib—CYP2D6—brain—bipolar disorder	0.000432	0.00104	CbGeAlD
Nilotinib—ABCB1—nervous system—bipolar disorder	0.000406	0.000981	CbGeAlD
Nilotinib—ABCB1—cerebellum—bipolar disorder	0.000382	0.000923	CbGeAlD
Nilotinib—ABCB1—brain—bipolar disorder	0.000311	0.000749	CbGeAlD
Nilotinib—PDGFRA—Signaling Pathways—DRD2—bipolar disorder	3.75e-05	6.54e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NRG1—bipolar disorder	3.74e-05	6.53e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—MTHFR—bipolar disorder	3.74e-05	6.53e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—ADCY2—bipolar disorder	3.74e-05	6.52e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—DRD3—bipolar disorder	3.73e-05	6.51e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—GSK3A—bipolar disorder	3.72e-05	6.48e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR1A—bipolar disorder	3.7e-05	6.46e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—S100B—bipolar disorder	3.69e-05	6.43e-05	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	3.69e-05	6.43e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NTRK2—bipolar disorder	3.67e-05	6.4e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NR1D1—bipolar disorder	3.67e-05	6.4e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HTR2A—bipolar disorder	3.67e-05	6.4e-05	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	3.66e-05	6.39e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—DRD3—bipolar disorder	3.65e-05	6.37e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TAC1—bipolar disorder	3.65e-05	6.36e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—GSK3A—bipolar disorder	3.64e-05	6.35e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—DRD4—bipolar disorder	3.62e-05	6.32e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NTRK1—bipolar disorder	3.58e-05	6.25e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—SNAP25—bipolar disorder	3.58e-05	6.25e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—DRD1—bipolar disorder	3.58e-05	6.24e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR2C—bipolar disorder	3.58e-05	6.24e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—DRD4—bipolar disorder	3.55e-05	6.19e-05	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL1B—bipolar disorder	3.54e-05	6.17e-05	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL1B—bipolar disorder	3.54e-05	6.17e-05	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—NR3C1—bipolar disorder	3.53e-05	6.15e-05	CbGpPWpGaD
Nilotinib—FGR—Immune System—IL1B—bipolar disorder	3.53e-05	6.15e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NCAN—bipolar disorder	3.51e-05	6.12e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—GSK3B—bipolar disorder	3.5e-05	6.11e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—S100B—bipolar disorder	3.48e-05	6.08e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NTRK2—bipolar disorder	3.48e-05	6.07e-05	CbGpPWpGaD
Nilotinib—CA9—Metabolism—POMC—bipolar disorder	3.47e-05	6.06e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—DRD3—bipolar disorder	3.46e-05	6.04e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NR1D1—bipolar disorder	3.46e-05	6.03e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—INS—bipolar disorder	3.45e-05	6.03e-05	CbGpPWpGaD
Nilotinib—CA9—Metabolism—INS—bipolar disorder	3.45e-05	6.03e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—GSK3B—bipolar disorder	3.45e-05	6.02e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—GSK3A—bipolar disorder	3.45e-05	6.02e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SLC5A3—bipolar disorder	3.44e-05	6e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NR1D1—bipolar disorder	3.43e-05	5.98e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—POMC—bipolar disorder	3.42e-05	5.96e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—ADCY2—bipolar disorder	3.41e-05	5.95e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NRG1—bipolar disorder	3.41e-05	5.95e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TCF7L2—bipolar disorder	3.4e-05	5.93e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NTRK1—bipolar disorder	3.39e-05	5.92e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NRG1—bipolar disorder	3.38e-05	5.89e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—DRD2—bipolar disorder	3.38e-05	5.89e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CLOCK—bipolar disorder	3.37e-05	5.88e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—MTHFR—bipolar disorder	3.37e-05	5.88e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—DRD4—bipolar disorder	3.36e-05	5.87e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—ADCY2—bipolar disorder	3.34e-05	5.82e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TCF7L2—bipolar disorder	3.33e-05	5.8e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NCAN—bipolar disorder	3.31e-05	5.77e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—DRD2—bipolar disorder	3.3e-05	5.76e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—S100B—bipolar disorder	3.3e-05	5.75e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—TPH2—bipolar disorder	3.29e-05	5.73e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—TSHB—bipolar disorder	3.29e-05	5.73e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CACNB2—bipolar disorder	3.29e-05	5.73e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NCAN—bipolar disorder	3.28e-05	5.72e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—GSK3B—bipolar disorder	3.27e-05	5.7e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—NRG1—bipolar disorder	3.25e-05	5.68e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SLC5A3—bipolar disorder	3.24e-05	5.65e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—DPYD—bipolar disorder	3.23e-05	5.64e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SLC5A3—bipolar disorder	3.21e-05	5.6e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR1A—bipolar disorder	3.2e-05	5.59e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—COMT—bipolar disorder	3.2e-05	5.58e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—GSK3B—bipolar disorder	3.19e-05	5.56e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—MAOA—bipolar disorder	3.18e-05	5.54e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—ADCY2—bipolar disorder	3.17e-05	5.53e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—ADCY2—bipolar disorder	3.17e-05	5.52e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TCF7L2—bipolar disorder	3.15e-05	5.5e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TAC1—bipolar disorder	3.15e-05	5.5e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—INS—bipolar disorder	3.14e-05	5.48e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—DRD2—bipolar disorder	3.13e-05	5.46e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—GSK3B—bipolar disorder	3.11e-05	5.42e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2C—bipolar disorder	3.09e-05	5.39e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—DRD1—bipolar disorder	3.09e-05	5.39e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—POMC—bipolar disorder	3.08e-05	5.38e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NRG1—bipolar disorder	3.07e-05	5.36e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR2A—bipolar disorder	3.07e-05	5.36e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—INS—bipolar disorder	3.06e-05	5.35e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—IMPA1—bipolar disorder	3.06e-05	5.33e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NTRK1—bipolar disorder	3.06e-05	5.33e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR2A—bipolar disorder	3.05e-05	5.31e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—GSK3B—bipolar disorder	3.02e-05	5.26e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NTRK2—bipolar disorder	3.01e-05	5.25e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CACNA1C—bipolar disorder	3e-05	5.24e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—NRG1—bipolar disorder	3e-05	5.24e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—DRD3—bipolar disorder	3e-05	5.22e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NTRK1—bipolar disorder	2.99e-05	5.22e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—GSK3A—bipolar disorder	2.98e-05	5.2e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—INS—bipolar disorder	2.98e-05	5.19e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—S100B—bipolar disorder	2.97e-05	5.18e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—GSK3B—bipolar disorder	2.95e-05	5.15e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—GSK3B—bipolar disorder	2.94e-05	5.14e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—POMC—bipolar disorder	2.93e-05	5.11e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PIK3C2A—bipolar disorder	2.93e-05	5.11e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—INS—bipolar disorder	2.91e-05	5.08e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NRG1—bipolar disorder	2.91e-05	5.08e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—S100B—bipolar disorder	2.91e-05	5.07e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—DRD4—bipolar disorder	2.91e-05	5.07e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—GSK3B—bipolar disorder	2.88e-05	5.03e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—GSK3B—bipolar disorder	2.87e-05	5e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CLOCK—bipolar disorder	2.85e-05	4.98e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NTRK1—bipolar disorder	2.84e-05	4.95e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL1B—bipolar disorder	2.82e-05	4.92e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—TSHB—bipolar disorder	2.78e-05	4.85e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—TPH2—bipolar disorder	2.78e-05	4.85e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CACNB2—bipolar disorder	2.78e-05	4.85e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR2A—bipolar disorder	2.77e-05	4.84e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—S100B—bipolar disorder	2.76e-05	4.81e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ADCY2—bipolar disorder	2.74e-05	4.77e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—DPYD—bipolar disorder	2.74e-05	4.77e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—GSK3B—bipolar disorder	2.73e-05	4.77e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TCF7L2—bipolar disorder	2.73e-05	4.76e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—GSK3B—bipolar disorder	2.72e-05	4.74e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—COMT—bipolar disorder	2.72e-05	4.74e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—DRD2—bipolar disorder	2.71e-05	4.73e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—MTHFR—bipolar disorder	2.71e-05	4.72e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MAOA—bipolar disorder	2.7e-05	4.7e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—INS—bipolar disorder	2.68e-05	4.68e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—SNAP25—bipolar disorder	2.63e-05	4.58e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR2A—bipolar disorder	2.62e-05	4.58e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NRG1—bipolar disorder	2.62e-05	4.57e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	2.6e-05	4.53e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—MTHFR—bipolar disorder	2.59e-05	4.51e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NRG1—bipolar disorder	2.57e-05	4.48e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CACNA1C—bipolar disorder	2.54e-05	4.44e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—IL1B—bipolar disorder	2.54e-05	4.43e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	2.52e-05	4.39e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CLOCK—bipolar disorder	2.49e-05	4.34e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	2.48e-05	4.32e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—GSK3B—bipolar disorder	2.48e-05	4.32e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—POMC—bipolar disorder	2.46e-05	4.28e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NTRK1—bipolar disorder	2.45e-05	4.28e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—GSK3B—bipolar disorder	2.45e-05	4.28e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.45e-05	4.27e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—INS—bipolar disorder	2.44e-05	4.26e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NRG1—bipolar disorder	2.43e-05	4.25e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—POMC—bipolar disorder	2.43e-05	4.24e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—TSHB—bipolar disorder	2.42e-05	4.23e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—TPH2—bipolar disorder	2.42e-05	4.23e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CACNB2—bipolar disorder	2.42e-05	4.23e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—INS—bipolar disorder	2.42e-05	4.22e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—IL1B—bipolar disorder	2.41e-05	4.2e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—S100B—bipolar disorder	2.38e-05	4.16e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—DPYD—bipolar disorder	2.38e-05	4.16e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR2A—bipolar disorder	2.36e-05	4.12e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—GSK3B—bipolar disorder	2.36e-05	4.12e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.34e-05	4.09e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ADCY2—bipolar disorder	2.32e-05	4.05e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CLOCK—bipolar disorder	2.32e-05	4.05e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR2A—bipolar disorder	2.31e-05	4.04e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—TSHB—bipolar disorder	2.28e-05	3.98e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—TPH2—bipolar disorder	2.28e-05	3.98e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CACNB2—bipolar disorder	2.28e-05	3.98e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—TPH2—bipolar disorder	2.26e-05	3.95e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—TSHB—bipolar disorder	2.26e-05	3.95e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CACNB2—bipolar disorder	2.26e-05	3.95e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NR1D1—bipolar disorder	2.26e-05	3.94e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—DPYD—bipolar disorder	2.25e-05	3.92e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—GSK3B—bipolar disorder	2.23e-05	3.89e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—DPYD—bipolar disorder	2.23e-05	3.88e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—SNAP25—bipolar disorder	2.22e-05	3.88e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CACNA1C—bipolar disorder	2.22e-05	3.87e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—POMC—bipolar disorder	2.21e-05	3.86e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—INS—bipolar disorder	2.2e-05	3.84e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MTHFR—bipolar disorder	2.19e-05	3.83e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR2A—bipolar disorder	2.19e-05	3.83e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—GSK3B—bipolar disorder	2.18e-05	3.8e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL1B—bipolar disorder	2.17e-05	3.78e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NCAN—bipolar disorder	2.16e-05	3.77e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	2.16e-05	3.77e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—INS—bipolar disorder	2.15e-05	3.75e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL1B—bipolar disorder	2.12e-05	3.7e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	2.12e-05	3.7e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—GSK3B—bipolar disorder	2.11e-05	3.69e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL1B—bipolar disorder	2.11e-05	3.68e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NRG1—bipolar disorder	2.1e-05	3.67e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—POMC—bipolar disorder	2.1e-05	3.66e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CACNA1C—bipolar disorder	2.09e-05	3.64e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—INS—bipolar disorder	2.08e-05	3.64e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CACNA1C—bipolar disorder	2.07e-05	3.61e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—POMC—bipolar disorder	2.07e-05	3.61e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—INS—bipolar disorder	2.06e-05	3.59e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	2.04e-05	3.55e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	2.02e-05	3.52e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL1B—bipolar disorder	2.01e-05	3.51e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.99e-05	3.47e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—COMT—bipolar disorder	1.99e-05	3.47e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MAOA—bipolar disorder	1.98e-05	3.45e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ADCY2—bipolar disorder	1.97e-05	3.43e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SNAP25—bipolar disorder	1.94e-05	3.38e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—GSK3B—bipolar disorder	1.9e-05	3.32e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2A—bipolar disorder	1.9e-05	3.31e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—POMC—bipolar disorder	1.89e-05	3.29e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—INS—bipolar disorder	1.88e-05	3.28e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—GSK3B—bipolar disorder	1.86e-05	3.25e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—POMC—bipolar disorder	1.85e-05	3.22e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—INS—bipolar disorder	1.84e-05	3.21e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.83e-05	3.18e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SNAP25—bipolar disorder	1.81e-05	3.16e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—GSK3B—bipolar disorder	1.77e-05	3.08e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—POMC—bipolar disorder	1.76e-05	3.06e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—POMC—bipolar disorder	1.75e-05	3.06e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—INS—bipolar disorder	1.75e-05	3.05e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—INS—bipolar disorder	1.74e-05	3.04e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1B—bipolar disorder	1.74e-05	3.03e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ADCY2—bipolar disorder	1.71e-05	2.99e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—COMT—bipolar disorder	1.69e-05	2.94e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MAOA—bipolar disorder	1.67e-05	2.92e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.62e-05	2.82e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MTHFR—bipolar disorder	1.61e-05	2.81e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ADCY2—bipolar disorder	1.6e-05	2.79e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.53e-05	2.67e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—GSK3B—bipolar disorder	1.53e-05	2.66e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—POMC—bipolar disorder	1.52e-05	2.64e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—INS—bipolar disorder	1.51e-05	2.63e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TPH2—bipolar disorder	1.49e-05	2.6e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TSHB—bipolar disorder	1.49e-05	2.6e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.49e-05	2.6e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—DPYD—bipolar disorder	1.47e-05	2.56e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—COMT—bipolar disorder	1.47e-05	2.56e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MAOA—bipolar disorder	1.46e-05	2.54e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—COMT—bipolar disorder	1.38e-05	2.41e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MAOA—bipolar disorder	1.37e-05	2.4e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—COMT—bipolar disorder	1.37e-05	2.39e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.37e-05	2.38e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MTHFR—bipolar disorder	1.36e-05	2.38e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MAOA—bipolar disorder	1.36e-05	2.38e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.33e-05	2.32e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—POMC—bipolar disorder	1.29e-05	2.24e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—INS—bipolar disorder	1.28e-05	2.23e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SNAP25—bipolar disorder	1.19e-05	2.08e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MTHFR—bipolar disorder	1.19e-05	2.07e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.12e-05	1.95e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MTHFR—bipolar disorder	1.11e-05	1.93e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—POMC—bipolar disorder	1.09e-05	1.9e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—INS—bipolar disorder	1.08e-05	1.89e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADCY2—bipolar disorder	1.06e-05	1.84e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—POMC—bipolar disorder	9.49e-06	1.66e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—INS—bipolar disorder	9.44e-06	1.65e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—COMT—bipolar disorder	9.04e-06	1.58e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MAOA—bipolar disorder	8.98e-06	1.57e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—POMC—bipolar disorder	8.94e-06	1.56e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—INS—bipolar disorder	8.89e-06	1.55e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—POMC—bipolar disorder	8.87e-06	1.55e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—INS—bipolar disorder	8.82e-06	1.54e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MTHFR—bipolar disorder	7.31e-06	1.28e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—POMC—bipolar disorder	5.85e-06	1.02e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—INS—bipolar disorder	5.81e-06	1.01e-05	CbGpPWpGaD
